The association of Group A streptococci with impetigo and other superficial skin infections has recently been reemphasized by studies from several different geographical areas (1-6). The original observations of Parker, Tomlinson, and Williams (1) and of Barrow (2), that Group A streptococci isolated from skin lesions seldom give a precipitin reaction with any of the M-typing antisera in general use, have subsequently been confirmed by studies of impetigo in children (3-5). Only 3 of 86 impetigo strains examined by Parker and coworkers (1) were typable by the precipitin method, as were only 4 of the 53 impetigo strains more recently reported by Markowitz et al. (3). Since the M antigen is generally believed to be an important factor in the virulence of Group A streptococci isolated from infections other than superficial skin lesions, the failure of production of this antigen by impetigo strains, if confirmed, would suggest an important difference between the pathogenesis of streptococcal skin infections and other streptococcal infections (7).
by all three sera. It is the latter which form a large proportion of strains found in skin lesions.
Characterization by T-agglutination of strains isolated from skin lesions of children during a study of pyoderma at the Cass Lake and Red Lake Indian reservations in Minnesota (5) gave results similar to those previously described (1) (2) (3) (4) . A total of 257 strains were examined; 43 % were of T pattern 3/13/B3264, 16% were of T pattern 8/25/Imp.19, and 16% were of T pattern 5/27/44, 11, or 12. A fourth T pattern, 15/17/19/23/47, accounted for 10 % of the pyoderma strains examined. In contrast to previous experience, a significant proportion of pyoderma strains isolated in this study (14%) gave precipitin reactions with Type 41 antiserum; these reactions were seen only among strains of T pattern 3/13/B3264. Since precipitin reactions due to M protein had seldom been found among pyoderma streptococci and Type 41 M had not been previously reported among strains of this agglutination pattern, it seemed of importance to establish beyond doubt the nature of the precipitating antigen in these strains. When this antigen was indeed found to be an M antigen, other nontypable pyoderma strains were studied for M antigens. This paper will demonstrate the occurrence of Type 41 M antigen and of three apparently new M antigens--Types Schoenborn, Hanson, and Kingbird--among Group A strains isolated from superficial skin infections.
Methods
The following strains of Group A streptococci, isolated from individual children in an epidemiologic study of skin infections and nephritis at the Cass Lake and Red Lake Indian reservations in Minnesota (5) were used in indirect bactericidal tests: Two stock Type 41 strains were also used in the experimental work: strain C101/10/1, a Type 41 strain which gave no agglutination with available T antisera-obtained from Dr. Rebecca Lancefield, and strain C101/100/10, a more highly mouse-passaged variant of the same strain.
Strains of T pattern 3/13/B3264
Streptococci were grown in commercial Todd-Hewitt broth (Difco Laboratories Inc., Detroit, Mich.). M antigen was extracted with N/5 hydrochloric acid and capillary precipitin tests were performed as described by Swift, Wilson, and Lancefield (9) . M-typing antisera of Types 1-6, 8, 9, 11-15, 17-19, 22-34, 36-44, 46-49, and 51 were used. Antisera for Types 27, 28, 34, 48, 49, and 51 were obtained through the kindness of Dr. Rebecca Lancefield and Type 9 antiserum was made in the Central Public Health Laboratory, Colindale, London, England. The remaining antisera were obtained from the Communicable Disease Center in Atlanta, Ga. Type 41 antisera were supplied by both the Communicable Disease Center (CDC Type 41 antiserum) and the Central Public Health Laboratory (CPHL Type 41 antiserum). T-agglutination sera were made at the Central Public Health Laboratory, and agglutination tests were performed by the method described by Williams (8) . The serum-opacity reaction produced by strains was determined by a modification (11) of the method described by Gooder (10) .
Vaccines and antisera were made by a modification of the Lancefield technique described by Moody et al. (12) . Cells were grown for 16-18 hr at 37°C in 1.6 liters of Todd-Hewitt broth, killed by heating at 56°C for 30 rain, washed three times in 0.9% saline, and suspended in 100 ml of 0.9% saline. Rabbits were immunized with 0.5-1.0 ml per injection of the vaccine, depending upon tolerance, in a schedule of three daily injections followed by 4 days of rest before the next injection. Antiserum to be used for typing was absorbed with heterologous strains (12) .
Indirect bactericidal tests were performed as described by Lancefield (13) . A 10 4 dilution of a 2-3 hr growth was made in Todd-Hewitt broth of strains to be tested and further diluted 1/4, 1/16, and 1/64 in Todd-Hewitt broth; 0.1 ml of each of the four dilutions was incorporated in a blood agar pour plate to determine the number of streptococcal chains inoculated into each tube. All antisera used were heated at 56°C for 30 rain prior to use. 0.1 ml of each of the four dilutions of ceils, 0.05 ml of antiserum, and 0.3 ml of fresh heparinized whole human blood were placed in 10 X 100 ml tubes. The tubes, capped with smooth rubber stoppers, were rotated at 8 g at 37°C for 3 hr. At the end of this time, a 0.1 ml sample from each tube was incorporated into blood agar pour plates. The plates were incubated at 37°C for 18 hr and a colony count was done; this figure is recorded in the results listed in subsequent tables of indirect bactericidal tests. The actual number of chains contained in each tube at the end of the tests may be determined by multiplying the recorded figure by a factor of 4.5.
Growth of strains in normal human blood was determined in a similar fashion with the exception that antiserum was not added to the system. Data from the studies of Lancefield (14, 15) would indicate that strains containing more than moderate amounts of M antigen grow in normal human blood so as to exceed the number of chains inoculated by a factor of at least 40 after 3 hr rotation at 37°C. For the purpose of this paper, a strain was considered to show significant growth if the number of chains obtained after 3 hr rotation at 37°C increased by a factor of 64 or greater beyond the number inoculated.
In order to estimate the frequency of occurrence of Type 41 and the new provisional types in skin lesions among children of the two Indian reservations, strains obtained from patients' initial skin cultures positive for Group A streptococci in this study (5) 
RESULTS

Type 41 among Pyoderma Strains of T-Agglutination Pattern 3/13/B3264.--
Among the 257 pyoderma strains isolated in initial cultures in the Indian reservation study, 35 (14%) were found to precipitate with Type 41 antiserum; strains whose extracts precipitated with this antiserum were all of T pattern 3/13/B3264. In order to investigate this precipitating antigen, a vaccine prepared from a 3/13/B3264 pyoderma strain producing the antigen, strain CV162, was injected into rabbits. Serum (No. 694) from an immunized rabbit after suitable absorption, gave a strong precipitin reaction with extracts of CV162 and of the stock Type 41 strain C101/10/1, but failed to react with extracts of any of the laboratory stock strains of other serotypes. Extracts of all oo indicates innumerable colonies with complete hemolysis of blood of the pour plate. 4000 indicates innumerable colonies with some areas of unhemolyzed blood. Plates containing 500 to 4000 colonies were estimated by counting one quarter of the plate and multiplying by four. In plates with less than 500 colonies the entire plate was counted. the 3/13/B3264 pyoderma strains which had been found to react with CDC Type 41 antiserum were found to react with No. 694 serum. Extracts of the 3/13/B3264 pyoderma strains which had not precipitated with CDC Type 41 antiserum did not react with No. 694 serum.
Gel diffusion tests were employed to compare the nature of the reaction seen with these antisera and extracts. CPHL Type 41 antiserum and serum No. 694 gave single lines of identity with extracts of CV162 and of C101/10/1. CDC Type 41 antiserum also gave a line of identity with these extracts, but with the more highly passaged strain C101/100/10 a second line appeared. Absorption of CDC Type 41 antiserum with CV162 cells removed the major precipitin line but not the second line. Thus the major line seen with all sera and extracts appeared to be identical. The antigen was shown to be trypsin-sensitive.
Indirect bactericidal tests were performed in the University of Minnesota laboratory on the two sera, CDC Type 41 and No. 694. The test streptococci included strains C101/10/1, CV162, and several other 3/13/B3264 pyoderma strains which had given a precipitin reaction with Type 41 antisera. Tests were made at the Central Public Health Laboratory (Colindale) on the sera CPHL Type 41, CDC Type 41, and No. 694. Results were similar in the two laboratories and representative findings with strains CV162 and C101/10/1 are shown in Table I .
In bactericidal systems containing either Type 41 or No. 694 antiserum, the stock Type 41 strain C101/10/1 was almost completely killed. These two antisera also caused marked reduction in the numbers of strain CV162 and of other 3/13/B3264 pyoderma strains which had given a precipitin reaction with Type 41 antisera, but never gave complete killing of any of them. In all these tests, serum No. 694 behaved exactly as CDC Type41 and CPHL Type 41 antiserum Absorption of the two stock Type 41 sera with extracts of strain CV162 and other similar 3/13/B3264 pyoderma strains removed the bactericidal activity from both. Our results then indicate that the pyoderma strains which had given a precipitin reaction with Type 41 antisera did, in fact, contain M protein of Type 41.
Strains of T-agglutination pattern 3/13/B3264 accounted for 111 of the 257 strains (43 %) isolated from the initial skin cultures obtained at the Indian reservation study (5) . 35 of these 3/13/B3264 strains (32 %) were found to be Type 41 strains. There was little nephritis seen in this study (5) , and none could be attributed to Type 41 strains. Type 41 strains with T pattern 3/13/ B3264 have also been isolated in skin cultures and throat cultures of several patients and from the blood of three patients with septicemia in the Minneapolis-St. Paul area.
At Colindale, 36 cultures from various parts of Britain, all with the T-agglutination pattern 3/13/B3264, were examined but only one gave a precipitin reaction with Type 41 serum. However, among 6 strains with T pattern 3/13/ B3264, isolated from skin lesions and burns in Canada and sent to Colindale, five were found to be Type 41.
Reports that Type 41 streptococci were prevalent in Trinidad (6) prompted a reexamination of a large collection of skin strains isolated there. In all, 365 cultures with the T-agglutination pattern 3/13/B3264 were tested with Type 41 serum at Colindale, but none of them gave a precipitin reaction with Type 41 serum.
Type Schoenborn (Type 52) among Pyoderma Strains of T-Agglutination
Pattern 3/13/B3264.--Despite the prevalence of pyodema strains agglutinating as T 3/13/B3264 in the studies on the Indian reservation, only 32 % were found to be Type 41 strains; the remainder (76 strains) were not typable with the available M-typing antisera. Nearly all strains of this T-agglutination pattern, regardless of whether they reacted with Type 41 antiserum, were serum-opacity negative, a finding which in other studies correlated with the presence of an M antigen (10, 16) . Two of these strains, CV686 and CV1060, were tested in an indirect bactericidal test in the presence of normal human blood with the addition of Type 6 and Type 41 antisera. The number of chains obtained after 3 hr incubation in the presence of either antiserum exceeded the number inoculated by a factor of 80-100. This finding suggested the possibility of an M antigen in these strains which was different from the Type 41 antigen. Table I for details of test.
Rabbits were immunized with a vaccine prepared from strain CV686 (isolated from patient Schoenborn). The antisera obtained produced strong precipitin reactions with CV686 extracts but only weak reactions with extracts of heterologous strains. After suitable absorption, the antiserum was tested with extracts of all established Group A streptococcal types and also with extracts of several pyoderma strains with agglutination patterns other than 3/13/B3264; no precipitation was obtained with any of these extracts. The absorbed antisera did, however, give a strong reaction with CV686 extract. Lancefield extracts prepared from all 111 initial skin isolates of T pattern 3/13/B3264 from the Indian reservation study were tested with absorbed CV686 antiserum. Moderate to strong precipitation was found with extracts of 40 of these strains. Strains of T pattern 3/13/B3264 previously classified as Type 41 strains did not react with this antiserum.
Indirect bactericidal tests with Type Schoenborn antiserum were performed with several strains which had shown precipitation with this antiserum; the results are shown in Table II born M antigens among skin isolates of T pattern 3/13/B3264, approximately one-third of the strains of this T pattern isolated in the Indian reservation study remained nontypable. The majority of these strains failed to produce a serum-opacity reaction. One such nontypable strain, CV 832 (isolated from patient Hanson), was found to grow well in rotated human blood. Sera obtained from rabbits immunized with a vaccine prepared from strain CV 832, after suitable absorption with heterologous strains, gave no precipitin reaction with extracts of all established types of Group A streptococci, but did give moderate precipitation with an extract of strain CV 832. The absorbed antiserum was tested with extracts of the initial skin isolates of T pattern 3/13/ B3264 from the Indian reservation study; no precipitation was found with 1 Potter, E. V. Personal communication.
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extracts of strains in this T pattern previously classified as Type 41 or Type Schoenborn, but moderate reactions were found with extracts of 22 of the 36 previously nontypable strains.
In indirect bactericidal tests (Table IV) See legend under Table I for details of test.
strains of this pattern were uniformly negative for the serum-opacity factor. One such strain examined, strain CV 581 (isolated from patient Kingbird), grew well in rotated normal human blood. Antisera obtained from rabbits immunized with a vaccine of strain CV 581, when suitably absorbed, were found to be specific in that they did not cause precipitation with extracts of all established types of Group A streptococci or extracts of nontypable pyoderma strains of heterologous serotype, but gave strong precipitation with an extract of strain CV 581. Extracts prepared from all 26 initial skin isolates of T pattern 15/17/19/23/47 from the Indian reservation gave strong precipitation with absorbed CV 581 antiserum.
Indirect bactericidal tests performed on several Type Kingbird strains with Type Kingbird antiserum are shown for strain CV 581 in Tables V and VI, and for strain CV 1085 in Table III were M-typable. Currently, 132 of the 257 strains (51%) are typable by the precipitin method with the use of the antisera for Type 41 and the new provisional types. During the same period of time as the Indian reservation study, 62 of 140 strains (44 %) of Group A streptococci isolated from throat cultures of children with pharyngitis in St. Paul-Minnesota were typable by the precipitin methodJ With the use of available antisera, including those of the new types, the proportion of streptococci from skin lesions which have an identifiable M antigen appears to be similar to that found with strains isolated in association with pharyngitis in Minnesota. 
Growth in Human Blood of Representative Pyoderma Streptococci.--Because
49 % of Group A streptococci isolated from skin lesions in the Indian reservation study are at present nontypable by the precipitin method, it was of interest to explore the possibility that these remaining nontypable strains might contain an unrecognized M antigen. Therefore, randomly selected strains of each T-agglutination pattern isolated at the reservations were tested for growth in heparinized whole human blood, rotated for 3 hr at 37 ° C. Two control strains--$43/137/10, a Type 6 strain whose extracts gave strong precipitation with Type 6 antiserum, and $43 glossy, a nontypable variant of the same strain--were tested similarly for purposes of comparison. The results of these tests are shown in Table IX . Growth in human blood is evident with all 8 of the nontypable pyoderma strains tested. With the possible exception of strain RL 1128, the number of chains found in each tube at the end of the test (the number of chains in a 0.1 ml sample multiplied by a factor of 4) exceeded the number inoculated by a factor of greater than 64. Their growth was indeed comparable to the growth of the known M-typable strain $43/137/10. In contrast, the non-M-typable strain $43 glossy was killed under identical test conditions. These findings are compatible with the possibility that the pyoderma strains tested, although nontypable in precipitin tests with currently available antisera, do contain an unidentified M antigen.
DISCUSSION
Attention was drawn in an earlier report from Colindale (1) to the infrequency with which Group A streptococci from skin lesions could be typed by the M-precipitin method. This was not taken as evidence that these organisms were necessarily M-negative, but simply that they did not appear to form the M antigens commonly present in strains with the same T-agglutination pattern which had been isolated from infections other than pyoderma in the same locality. In England and Wales, for example, over half of the cultures agglutinated by one or more of the sera 3, 13, and B3264 gave a precipitin reaction with 3M antiserum, but the proportion of 3M-positive cultures among members of the 3/13/B3264 T pattern was 90% for scarlet fever, 59% for acute pharyngitis and 14% for impetigo (17) . The remaining 3/13/B3264 strains from impetigo lesions could not be typed with available M antisera.
The results of the present investigation show that a large proportion (87 %) of Group A streptococci with the T pattern 3/13/B3264 isolated from the skin lesions of children from two Indian reservations in Minnesota produced M antigens of Type 41, Type Schoenborn, or Type Hanson. All pyoderma strains of a second T pattern 15/17/19/23/47, were found to elaborate still a fourth M antigen, Type Kingbird. With the use of Type 41 antiserum and the antisera of the new provisional types, half of the pyoderma strains isolated in the Indian reservation study were found to produce an M antigen. In a different locality, the Minneapolis-St. Paul area, nearly 40 % (18 of 48) of pyoderma strains were M-typable by the use of the same antisera. That other pyoderma strains which are currently nontypable with available M-typing antisera may contain unidentified M antigens is suggested by the excellent growth in human blood of all but one of the eight strains tested. Our findings indicate that Group A streptococci isolated from superficial skin infections commonly produce an M antigen.
It seems probable that the delay in recognition of these M antigens among pyoderma streptococci is principally a reflection that pyoderma strains have not been systematically examined for new M antigens. With the notable exception of Type 49 (the original Red Lake strain), it would appear that at the time most of the studies defining the established types were performed, attention was centered predominantly on strains commonly associated with pharyngitis, scarlet fever, or acute rheumatic fever. If, as has been suggested by the English workers (1, 2, 17) , superficial skin infections are associated with distinct streptococcal serotypes not commonly encountered in other streptococcal infections, it is not surprising that these new types isolated from skin lesions were not identified among strains isolated from sources other than skin. Nor is it surprising that these and other skin strains have been classified as nontypable when tested against a battery of M-typing antisera developed from strains obtained predominantly from non-skin sources.
In view of the previous reports of the greater frequency of isolation of non-M-typable 3/13/B3254 strains from skin lesions than from pharyngitis, it is tempting to speculate that the newly described M types in this T pattern--Types 41, Schoenborn, and Hanson--may be more commonly associated with skin infections. In limited studies on strains isolated in the Minneapolis-St. Paul area, both Type 41 and Type Schoenborn were indeed isolated more frequently from skin lesions than from pharyngitis. More extensive screening of strains from various sources with Type 41 antiserum and with the antisera of the new provisional types is needed in order to determine whether strains of these types are more commonly associated with skin infections and thus can be truly considered to be impetigo streptococcL
The recognition of the M antigens among pyoderma strains was facilitated by the use of three separate microbiologic tools which may prove useful in defining further M types. These include the T-agglutination method of classifying Group A streptococci, a screening test of strains for the serum-opacity reaction, and a test for the growth of selected strains in rotated whole human blood. The first method, T-agglutination, allowed classification of 94 % of all Group A streptococci isolated in the Indian reservation study. Selection of strains for vaccines and for subsequent testing with the M antisera produced was accomplished more rationally with the use of this system than would have been possible had we been presented with a large number of unidentified non-M-typable strains without it.
A second procedure found useful in our studies is a screening test for the serum-opacity reaction. Gooder (10) and KShler (16) determined that types of Group A streptococci for which the production of suitable M-typing sera was relatively easily accomplished generally failed to produce the serum-opacity reaction. Conversely, types for which the production of typing sera was difficult, as well as the majority of non-M-typable strains, were found to produce the serum-opacity reaction. Recent work in the Minnesota laboratory on the serumopacity reaction has confirmed these findings (11) . Since nearly all of the 3/13/B3264 isolates and all of the 15/17/19/23/47 isolates from the Indian reservation study failed to produce the serum-opacity reaction, we hypothesized that these strains should have a demonstrable M antigen. Our success in producing M-typing antisera for Types Schoenborn, Hanson, and Kingbird (all strains of these types examined have failed to produce a serum-opacity reaction) provides further confirmation of Gooder's and K6hler's findings of the curious, generally inverse, relationship of these two streptococcal antigens.
The third procedure utilized in this study had previously been used in defining M types (13, 14) . Selected strains in the two T-agglutination patterns which failed to produce a serum-opacity reaction were tested for growth in whole human blood which was rotated to insure contact between the organisms and the leukocytes. Resistance to phagocytosis of Group A streptococci in rotated human blood has been demonstrated to be dependent on the presence of an M antigen on the organisms (13) (14) (15) 18) . Failure of a strain to grow in rotated human blood is subject to several interpretations, including the absence of M protein on the strain or the presence of type-specific antibody in the blood used for testing. Failure to grow in normal human blood, especially if only one volunteer is tested, does not necessarily mean that the strain is M-negative. On the other hand, growth of a Group A streptococcus in rotated human blood without type-specific antibody is characteristic of M-producing strains. In this study, the excellent growth of the strains tested suggested that they produced an M antigen despite their lack of precipitin reactions with available Mtyping antisera. The combined use of the T-agglutination system, a screening test for the serum-opacity reaction, and a test of the growth of selected strains in rotated human blood thus permitted a rational investigation of M antigens on these previously nontypable pyoderma strains. It seems likely that these three methods may be useful in further investigation of the M antigens of currently unidentified strains.
The identification of Type 41 and the provisional types among pyoderma streptococci should facilitate future investigations of superficial skin infections and their sequelae. The relative ease of identification of the new M antigens suggests that further investigation of strains in the other common pyoderma T patterns may be fruitful. It is now possible to identify precisely a significant proportion of pyoderma strains by the most specific typing method available,
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the M-precipitin method. The new typing antisera should afford the same precision of typing in studies of streptococcal skin infections as has been accompushed in studies of other streptococcal diseases. Further insight into the immune response of patients with streptococcal pyoderma should also be attainable by determining human type-specific antibodies to the M antigens which have been newly identified. With respect to M proteins it would seem that pyoderma strains must be considered as having the same potential virulence as strains causing other kinds of streptococcal infection. The recent isolation in our laboratory of Type 41 strains from the blood of three patients with septicemia and skin infections is evidence in support of the virulence of pyoderma strains. Extended investigation with the new typing antisera and that of Type 41 is indicated to establish more fully the role of these strains in streptococcal infections and their sequelae. Approximately half of the pyoderma strains examined were found to produce an M antigen; the proportion of M-typable strains from skin infections was found to be similar to that currently found in throat cultures of children with pharyngitis. The demonstration of M antigens in streptococci from skin lesions provides evidence of their potential virulence and should facilitate their classification in subsequent epidemiological studies.
